Nexus Pharmaceuticals, LLC announces the launch of Cyclophosphamide Injection, available in ready to dilute 2.5 mL fill and 5 mL fill multiple-dose vials. As the first AP Rated Generic to Dr. Reddy's, ...

Cyclophosphamide is a generic injectable solution and capsule prescribed to treat conditions such as certain cancers and nephrotic syndrome. The cost of cyclophosphamide, with and without insurance, ...

Patients undergoing matched-donor stem cell transplants lived four times longer without episodes of graft-versus-host disease (GVHD) with post-transplant cyclophosphamide-cyclosporin prophylaxis, a ...

PHILADELPHIA -- Rituximab (Rituxan) matched IV cyclophosphamide for improving lung function in patients with interstitial lung disease (ILD) related to systemic sclerosis and other connective tissue ...

Please provide your email address to receive an email when new articles are posted on . New Pan American League of Associations for Rheumatology recommendations include remission maintenance ...

Please provide your email address to receive an email when new articles are posted on . Week-22 remission rates were 81% among patients using infliximab and 56% in those on cyclophosphamide. Mild to ...

Bortezomib is a potent first-in-class proteasome inhibitor. 15 In a pivotal large phase-III study in relapsed MM, bortezomib proved superior to dexamethasone in both event-free and overall survival. 4 ...

Uppsala, Sweden - The risk of bladder cancer rises steadily with increasing cumulative dose of cyclophosphamide in patients with Wegener's granulomatosis (WG), although some of this risk is ...

Rituximab and cyclophosphamide are equally effective in achieving remission or low disease activity rates in childhood-onset antineutrophil cytoplasmic antibody–associated vasculitis (AAV), and those ...

Neoadjuvant metformin along with systemic therapy increase pathological complete responses in breast cancer: Results of a cross-sectional study, Hospital Mexico, Costa Rica. Scalp-cooling achieved by ...

Clinical Characteristics and Outcomes of Caribbean Patients With Adult T-Cell Lymphoma/Leukemia at Two Affiliated New York City Hospitals Twenty patients (17 with platinum-resistant and 3 with ...